Results 151 to 160 of about 39,247 (186)

Cardiac involvement in beta-thalassemia major and beta-thalassemia intermedia.

Hemoglobin, 2005
The forms and severity of cardiac complications were investigated in patients with asymptomatic thalassemia intermedia and thalassemia major by M-mode, bi-dimensional echocardiography (ECHO) and echo-Doppler. Twenty-eight patients of both sexes with beta-thalassemia intermedia (beta-TI), mean age 23.2 +/- 6.3 years, untransfused or minimally transfused,
Mara, Ferrara, Sofia M R, Matarese, Barbara, Borrelli, Angelo, Perrotta, Gelsomina, Simeone, Natalizia, Greco, Diana, Iarussi, Luigi, Esposito   +7 more
openaire   +1 more source

Beta Thalassemia

Hematology/Oncology Clinics of North America, 2019
Eugene Khandros, Janet L. Kwiatkowski
openaire   +1 more source

Beta‐Thalassemias

2004
Antonio Cao, Renzo Galanello
openaire   +2 more sources

In Brief: Casgevy for Beta Thalassemia

The Medical Letter on Drugs and Therapeutics
Exagamglogene autotemcel (Casgevy – Vertex), a cell-based gene therapy recently approved for treatment of sickle cell disease1, has now been approved by the FDA for treatment of patients ≥12 years old with transfusion-dependent beta thalassemia.
openaire   +2 more sources

Beta Thalassemia

2022
openaire   +1 more source

Characterization and Comparison of the Red Blood Cell Membrane Damage in Severe Human Alpha- and Beta-Thalassemia

Blood, 1992
E Shinar, R Advani, S L Schrier
exaly  

Molecular Basis of Beta Thalassemia in the South of Thailand

American Journal of Hematology, 1992
Y Fukumaki
exaly  

Beta-Thalassemia

2021
openaire   +1 more source

Guidelines for Diagnosis and Management of Beta-Thalassemia Intermedia

Pediatric Hematology and Oncology, 2014
Ali Taher, Mehran Karimi, Vincenzo De Sanctis   +2 more
exaly  

Beta-thalassemia.

The New England journal of medicine, 2005
Deborah, Rund, Eliezer, Rachmilewitz
openaire   +1 more source